India to Myanmar: Febuxostat Export Trade Route

The India to Myanmar Febuxostat corridor is one of India's established pharmaceutical export routes, with 36 shipments documented worth a combined $299.1K USD. The route is dominated by STALLION LABORATORIES PVT LTD, which alone accounts for roughly 21% of all export value, reflecting the consolidated nature of India's febuxostat manufacturing sector.

Across 16 active suppliers, the average shipment value stands at $8.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with febuxostat's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 34.0%, placing it at rank #4 among India's top febuxostat export destinations globally.

On the import side, key buyers of Indian febuxostat in Myanmar include JDS CO LTD, J D S CO LTD NO 9 YAWMINGYI, M/S BIO SYSTEM (BIO SYS) COMPANY and 15 others. JDS CO LTD is the single largest importer with 6 shipments valued at $54.7K USD.

India's febuxostat exports to Myanmar are driven primarily by a handful of large-scale manufacturers. STALLION LABORATORIES PVT LTD with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STALLION LABORATORIES PVT LTD, LUPIN LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 56% of total trade value on this route. The average shipment value of $8.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as oxiluric 40 mg tablet 10x10(febuxostat tablets 40 mg)b/no.24122401e m/d.06.2024e/d.05.2026 and furic 40mg x100s febuxostat tablets 40mg bno jb01107 5817 packs, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, JDS CO LTD is the largest importer with 6 shipments worth $54.7K USD — representing 18% of all febuxostat imports from India on this route. A total of 18 buyers are active on this corridor.